Patterson Companies Announces Doug Jones as President, Companion Animal Group

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that Doug Jones has joined Patterson Animal Health as President of the Companion Animal Group based in Greeley, Colo.

"We are excited to have Doug on our team. He is a proven leader with an exceptional track record," said John Adent, CEO of Patterson Animal Health. "I look forward to working with him to further enhance our product and service offerings to our companion animal veterinarians."

Jones joins Patterson Companies after spending the past six years with Merial North America where he served as head of Merial's U.S. Pets Sales and National Accounts teams, and most recently as president of Merial North America. Jones was also a key member of the company's Regional Strategic Management Committee.

"We are delighted to have Doug join our Patterson leadership team," added Scott Anderson, Chairman and CEO of Patterson Companies. "Our commitment to our customers begins with hiring exceptional talent who can effectively lead our ability to deliver customized solutions. I am confident Doug's industry experience and vision will drive business growth in our companion animal business."

Earlier in his career, Jones was a business consultant for PricewaterhouseCoopers and The North Highland Company. He holds an undergraduate degree from Vanderbilt University and an MBA from the University of Texas at Austin.

About Patterson Companies, Inc.
Patterson Companies, Inc. is a value-added distributor serving the dental and animal health markets.
Dental Market
Patterson Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.
Animal Health Market
Patterson Animal Health, formerly Patterson Veterinary, is a leading, full-line distributor in North America and the U.K. of animal health products, services and technologies to both the production-animal and companion-pet markets.

Contacts
Patterson Companies, Inc.
John M. Wright, 651-686-1364
Vice President, Investor Relations

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…